Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Titel:
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Auteur:
Kwon, Eugene D Drake, Charles G Scher, Howard I Fizazi, Karim Bossi, Alberto van den Eertwegh, Alfons J M Krainer, Michael Houede, Nadine Santos, Ricardo Mahammedi, Hakim Ng, Siobhan Maio, Michele Franke, Fabio A Sundar, Santhanam Agarwal, Neeraj Bergman, Andries M Ciuleanu, Tudor E Korbenfeld, Ernesto Sengeløv, Lisa Hansen, Steinbjorn Logothetis, Christopher Beer, Tomasz M McHenry, M Brent Gagnier, Paul Liu, David Gerritsen, Winald R